NCT03134352View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema

PHASE2CompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

April 26, 2017

Primary Completion Date

May 25, 2018

Study Completion Date

September 10, 2018

Conditions
Eczema
Interventions
DRUG

ZL-3101

A brown ointment, 10g/tube, 0.4g herb/g ointment, Topical

DRUG

Placebo

A brown ointment, 10g/tube, 0.02 g herb/g ointment (5% of Fugan active ointment), Topical

Trial Locations (6)

Unknown

Beijing Hospital of Traditional Chinese Medicine, Beijing

Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing

Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing

Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing

Shanghai Dermatology Hospital, Shanghai

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM, Shanghai

All Listed Sponsors
lead

Zai Lab Pty. Ltd.

INDUSTRY

NCT03134352 - Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema | Biotech Hunter | Biotech Hunter